<unk>  is used in short-term (i.e., a few weeks) treatment of obesity, in combination with a regimen of weight reduction based on caloric restriction, exercise, and behavior modification in people with a body mass index greater than 30, or in those with a body mass index greater than 27 in the presence of risk factors such as hypertension, diabetes, or hyperlipidemia.<unk>  is not currently available as a commercially marketed and FDA-regulated prescription agent for the treatment of obesity. There is a Swiss study investigating its efficacy in treating ADHD.
Mazindol
Cloroqualone
Eclabium
Meptazinol
Triethylenetetramine
Nalmefene
Pipofezine
Michellamine